Raghu Tadagavadi Email

Executive Director, Nonclinical Development and Safety . Century Therapeutics

Current Roles

Employees:
281
Revenue:
$35.2M
About
Our genetically-engineered, universal iPSCs-derived immune effector cell products (NK, T, Dendritic cells, and macrophage) are designed to specifically target hematologic and solid tumor cancers. Our commitment to developing off-the-shelf cell therapies will expand patient access and provides an unparalleled opportunity to advance the course of cancer care.
Century Therapeutics Address
25 N. 38th Street
Philadelphia, PA
United States

Past Companies

Century Therapeutics, IncExecutive Director, Nonclinical Development and Safety
Legend BiotechSenior Director, Preclinical Development and Safety
Legend BiotechDirector, Preclinical Development and Safety

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.